Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Flu”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01594320
What this trial is testing

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Who this might be right for
Influenza (Pandemic)
Novavax 333
Early research (Phase 1)Study completedNCT02295813
What this trial is testing

Safety and Pharmacokinetics Study of FBF001

Who this might be right for
Avian Influenza
Fab'entech 16
Not applicableStudy completedNCT00428753
What this trial is testing

China Case Control Avian Influenza

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableWithdrawnNCT00417560
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses

Who this might be right for
Influenza
Centers for Disease Control and Prevention
Testing effectiveness (Phase 2)Study completedNCT00545701
What this trial is testing

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT01006798
What this trial is testing

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Who this might be right for
Bird FluInfluenza
Emergent BioSolutions 166
Large-scale testing (Phase 3)Study completedNCT02612909
What this trial is testing

A Safety and Immunogenicity Study of IVACFLU-A/H5N1

Who this might be right for
Avian Influenza
Institute of Vaccines and Medical Biologicals, Vietnam 930
Early research (Phase 1)WithdrawnNCT02177734
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01987011
What this trial is testing

Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

Who this might be right for
Influenza
Green Cross Corporation 420
Early research (Phase 1)Study completedNCT06417853
What this trial is testing

Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP)

Who this might be right for
H7N9 Influenza
Vaxxas Pty Ltd 267
Early research (Phase 1)Study completedNCT00297050
What this trial is testing

Safety and Dose Study of Peramivir for Influenza Treatment

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00900588
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Very early researchStudy completedNCT03277456
What this trial is testing

Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Who this might be right for
Human Volunteers
Barinthus Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT00908687
What this trial is testing

A/H5N1/LT Dose Ranging Study

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00478816
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines

Who this might be right for
Prophylaxis of Avian Influenza Vaccine
Novartis Vaccines 58
Testing effectiveness (Phase 2)Study completedNCT00561184
What this trial is testing

Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine

Who this might be right for
Avian Influenza
Novartis Vaccines 47
Testing effectiveness (Phase 2)Study completedNCT00914771
What this trial is testing

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Who this might be right for
Pandemic H5N1 Influenza
Novartis Vaccines 722
Early research (Phase 1)Study completedNCT02957656
What this trial is testing

Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 53
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation